Abstract
The NMR derived translational diffusion coefficients were performed on unlabeled and uniformly labeled 13C,15N human insulin in water, both in neat, with zinc ions only, and in pharmaceutical formulation, containing only m-cresol as phenolic ligand, glycerol and zinc ions. The results show the dominant role of the pH parameter and the concentration on aggregation. The diffusion coefficient Dav was used for monitoring the overall average state of oligomeric ensemble in solution. The analysis of the experimental data of diffusion measurements, using the direct exponential curve resolution algorithm (DECRA) allows suggesting the two main components of the oligomeric ensemble. The 3D HSQC-iDOSY, (diffusion ordered HSQC) experiments performed on 13C, 15N-fully labeled insulin at the two pH values, 4 and 7.5, allow for the first time a more detailed experimental observation of individual components in the ensemble. The discussion involves earlier static and dynamic laser light scattering experiments and recent NMR derived translational diffusion results. The results bring new informations concerning the preparation of pharmaceutical formulation and in particular a role of Zn2+ ions. They also will enable better understanding and unifying the results of studies on insulin misfolding effects performed in solution by diverse physicochemical methods at different pH and concentration.
Graphical Abstract
Similar content being viewed by others
Abbreviations
- DOSY:
-
Diffusion ordered spectroscopy
- DECRA:
-
Direct exponential curve resolution algorithm
- PFGSE NMR:
-
Pulse field gradient spin echo NMR
- 3D HSQC-iDOSY:
-
Heteronuclear single quantum correlation-internal encoded diffusion ordered spectroscopy
- Dav × 10−10 m2 s−1 :
-
Translational diffusion coefficient for assembly of oligomers
- Di × 10−10 m2 s−1 :
-
Translational diffusion coefficient for individual oligomer
References
Ahmad A, Millett IS, Doniach S, Uversky VN, Fink AL (2003) Partially folded intermediates in insulin fibrillation. Biochemistry 42(39):11404–11416
Ahmad A, Millett IS, Doniach S, Uversky VN, Fink AL (2004) Stimulation of insulin fibrillation by urea-induced intermediates. J Biol Chem 279(15):14999–15013
Antałek B, Windig W (1996) Generalized rank annihilation method applied to a single multicomponent pulsed gradient spin echo NMR data set. J Am Chem Soc 118:10331–10332
Auge S, Schmit PO, Crutchfield CA, Islam MT, Harris DJ, Durand E, Clemancey M, Quoineaud AA, Lancelin JM, Prigent Y, Taulelle F, Delsuc MA (2009) NMR measure of translational diffusion and fractal dimension. Application to molecular mass measurement. J Phys Chem B 113(7):1914–1918
Bednarek E, Sitkowski J, Bocian W, Borowicz P, Plucienniczak G, Stadnik D, Surmacz-Chwedoruk W, Jaworska B, Kozerski L (2017) Structure and pharmaceutical formulation development of a new long-acting recombinant human insulin analog studied by NMR and MS. J Pharm Biomed Anal 135:126–132
Birnbaum DT, Kilcomons MA, DeFelippis MR, Beals JM (1997) Assembly and dissociation of human insulin and LysB28ProB29-insulin hexamers: a comparison study. Pharm Res 14(1):25–36
Bocian W, Borowicz P, Mikołajczyk J, Sitkowski J, Tarnowska A, Bednarek E, Głąbski T, Tejchman-Małecka B, Bogiel M, Kozerski L (2008a) NMR structure of biosynthetic engineered human insulin monomer B31Lys-B32Arg in water/acetonitrile solution. Comparison with the solution structure of native human insulin monomer. Biopolymers 89(10):820–830
Bocian W, Sitkowski J, Tarnowska A, Bednarek E, Kawęcki R, Koźmiński W, Kozerski L (2008b) Direct insight into insulin aggregation by 2D NMR complemented by PFGSE NMR. Proteins 71(3):1057–1065
Bolli GB, Owens DR (2000) Insulin glargine. Lancet 356(9228):443–445
Bonaccio M, Ghaderi N, Borchardt D, Dunn MF (2005) Insulin allosteric behavior: detection, identification, and quantification of allosteric states via 19F NMR. Biochemistry 44(21):7656–7668
Borowicz P, Bocian W, Sitkowski J, Bednarek E, Mikiewicz-Sygula D, Blazej-Sosnowska S, Bogiel M, Rusek D, Kurzynoga D, Kozerski L (2011) Novel recombinant insulin analogue with flexible C-terminus in B chain. NMR structure of biosynthetic engineered A22G-B31K-B32R human insulin monomer in water/acetonitrile solution. Int J Biol Macromol 49(4):548–554
Borowicz P, Bocian W, Sitkowski J, Bednarek E, Mikiewicz-Sygula D, Kurzynoga D, Stadnik D, Surmacz-Chwedoruk W, Kozminski W, Kozerski L (2013) “Biosynthetic engineered B28(K)-B29(P) human insulin monomer structure in water and in water/acetonitrile solutions. J Biomol NMR 55(3):303–309
Brange J (ed) (1987) Galenics of insulin. Springer-Verlag, Berlin
Brange J, Andersen L, Laursen ED, Meyn G, Rasmussen E (1997) Toward understanding insulin fibrillation. J Pharm Sci 86(5):517–525
Brems DN, Alter LA, Beckage MJ, Chance RE, DiMarchi RD, Green LK, Long HB, Pekar AH, Shields JE, Frank BH (1992) Altering the association properties of insulin by amino acid replacement. Protein Eng 5(6):527–533
Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416(6880):507–511
Chang X, Jorgensen AM, Bardrum P, Led JJ (1997) Solution structures of the R6 human insulin hexamer. Biochemistry 36(31):9409–9422
Chen F, Gulbakan B, Weidmann S, Fagerer SR, Ibanez AJ, Zenobi R (2016) Applying mass spectrometry to study non-covalent biomolecule complexes. Mass Spectrom Rev 35(1):48–70
Choi WE, Brader ML, Aguilar V, Kaarsholm NC, Dunn MF (1993) The allosteric transition of the insulin hexamer is modulated by homotropic heterotropic interactions. Biochemistry 32(43):11638–11645
Ciszak E, Beals JM, Frank BH, Baker JC, Carter ND, Smith GD (1995) Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulin. Structure 3(6):615–622
Danielsson J, Jarvet J, Damberg P, Gräslund A (2002) Translational diffusion measured by PFG-NMR on full length and fragments of the Alzheimer Aβ(1–40) peptide. Determination of hydrodynamic radii of random coil peptides of varying length. Mag. Reson Chem 40:S89–S97
Dobson CM (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24(9):329–332
Dobson CM (2001) The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci 356(1406):133–145
Dobson CM, Karplus M (1999) “The fundamentals of protein folding: bringing together theory and experiment. Curr Opin Struct Biol 9(1):92–101
Dzwolak W, Grudzielanek S, Smirnovas V, Ravindra R, Nicolini C, Jansen R, Loksztejn A, Porowski S, Winter R (2005) Ethanol-perturbed amyloidogenic self-assembly of insulin: looking for origins of amyloid strains. Biochemistry 44(25):8948–8958
Garcia De La Torre, J, Huertas ML, Carrasco B (2000) Calculation of hydrodynamic properties of globular proteins from their atomic-level structure. Biophys J 78(2):719–730
Hilton GR, Benesch JL (2012) Two decades of studying non-covalent biomolecular assemblies by means of electrospray ionization mass spectrometry. J R Soc Interface 9(70):801–816
Hua QX, Weiss MA (2004) Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J Biol Chem 279(20):21449–21460
Huus K, Havelund S, Olsen HB, van de Weert M, Frokjaer S (2005) Thermal dissociation unfolding of insulin. Biochemistry 44(33):11171–11177
Hvidt S (1991) Insulin association in neutral solutions studied by light scattering. Biophys Chem 39(2):205–213
Johnson CS (1999) Diffusion ordered NMR spectroscopy: principles and applications. Prog Nucl Magn Reson 34:203–255
Kadima W, Øgendal L, Bauer R, Kaarsholm N, Brodersen K, Hansen JF, Porting P (1993) “The influence of ionic strength and pH on the aggregation properties of zinc-free insulin studied by static and dynamic laser light scattering. Biopolymers 33(11):1643–1657
Konijnenberg A, Butterer A, Sobott F (2013) Native ion mobility-mass spectrometry and related methods in structural biology. Biochim Biophys Acta 1834(6):1239–1256
Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB (2000) Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49(12):2142–2148
Lougheed WD, Albisser AM, Martindale HM, Chow JC, Clement JR (1983) Physical stability of insulin formulations. Diabetes 32(5):424–432
Margiolaki I, Giannopoulou AE, Wright JP, Knight L, Norrman M, Schluckebier G, Fitch AN, Von Dreele RB (2013) High-resolution powder X-ray data reveal the T(6) hexameric form of bovine insulin. Acta Crystallogr D Biol Crystallogr 69(Pt 6):978–990
Mikiewicz D, Bierczynska-Krzysik A, Sobolewska A, Stadnik D, Bogiel M, Pawlowska M, Wojtowicz-Krawiec A, Baran PA, Lukasiewicz N, Romanik-Chruscielewska A, Sokolowska I, Stadnik J, Borowicz P, Plucienniczak G, Plucienniczak A (2017) Soluble insulin analogs combining rapid- and long-acting hypoglycemic properties: from an efficient E. coli expression system to a pharmaceutical formulation. PLoS ONE 12(3):e0172600
Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR (1999) Insulin as part (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care 22(9):1501–1506
Nielsen L, Frokjaer S, Brange J, Uversky VN, Fink AL (2001a) Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 40(28):8397–8409
Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, Vyas S, Uversky VN, Fink AL (2001b) Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40(20):6036–6046
Norman M, Stahl K, Schluckebier G, Al-Karadaghi S (2006) Characterization of insulin microcrystals using powder diffraction and multivariate data analysis. J Appl Crystallogr 39:391–400
Owens DR (2007) Review: Insulin glulisine: the potential for improved glycaemic control. Br J Diabetes Vasc Dis 7:60–66
Pagel K, Wagner SC, Samedov K, von Berlepsch H, Bottcher C, Koksch B (2006) Random coils, beta-sheet ribbons, and alpha-helical fibers: one peptide adopting three different secondary structures at will. J Am Chem Soc 128(7):2196–2197
Patil SM, Keire DA, Chen K (2017) Comparison of NMR and dynamic light scattering for measuring diffusion coefficients of formulated insulin: implications for particle size distribution measurements in drug products. AAPS J 19(6):1760–1766
Roy M, Brader ML, Lee RW, Kaarsholm NC, Hansen JF, Dunn MF (1989) Spectroscopic signatures of the T to R conformational transition in the insulin hexamer. J Biol Chem 264(32):19081–19085
Shakhnovich E (2006) Protein folding thermodynamics and dynamics: where physics, chemistry, and biology meet. Chem Rev 106(5):1559–1588
Shi Z, Chen K, Liu Z, Kallenbach NR (2006) Conformation of the backbone in unfolded proteins. Chem Rev 106(5):1877–1897
Smith GD, Dodson GG (1992) The structure of a rhombohedral R6 insulin hexamer that binds phenol. Biopolymers 32(4):441–445
Smith GD, Swenson DC, Dodson EJ, Dodson GG, Reynolds CD (1984) Structural stability in the 4-zinc human insulin hexamer. Proc Natl Acad Sci USA 81(22):7093–7097
Smith GD, Pangborn WA, Blessing RH (2003) The structure of T6 human insulin at 1.0 A resolution. Acta Crystallogr D Biol Crystallogr 59(Pt 3):474–482
Smith MI, Sharp JS, Roberts CJ (2007) Nucleation and growth of insulin fibrils in bulk solution and at hydrophobic polystyrene surfaces. Biophys J 93(6):2143–2151
Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81(11):678–699
Tantipolphan R, Romeijn S, Engelsman J, Torosantucci R, Rasmussen T, Jiskoot W (2010) Elution behavior of insulin on high-performance size exclusion chromatography at neutral pH. J Pharm Biomed Anal 52(2):195–202
Urbańczyk M, Bernin D, Koźmiński W, Kazimierczuk K (2013) Iterative thresholding algorithm for multiexponential decay applied to PGSE NMR data. Anal Chem 85(3):1828–1833
Urbańczyk M, Koźmiński W, Kazimierczuk K (2014) Accelerating diffusion-ordered NMR spectroscopy by joint sparse sampling of diffusion and time dimensions. Angew Chem Int Ed 53(25):6464–6467
Uversky VN, Garriques LN, Millett IS, Frokjaer S, Brange J, Doniach S, Fink AL (2003) Prediction of the association state of insulin using spectral parameters. J Pharm Sci 92(4):847–858
Weiss MA (2013) Design of ultra-stable insulin analogues for the developing world. J Health Spec 1(2):59–70
Wider G, Døtsch V, Wüthrich K (1994) Self-compensating pulsed magnetic-field gradients for short recovery times. J Magn Reson A 108(2):255–258
Windig W, Antałek B (1997) Direct exponential curve resolution algorithm (DECRA): a novel application of the generalized rank annihilation method for a single spectral mixture data set with exponentially decaying contribution profiles. Chemom Intell Lab Syst 37:241–254
Wu DH, Chen AD, Johnson CS (1995) An improved diffusion-ordered spectroscopy experiment incorporating bipolar-gradient pulses. J Magn Reson A 115(2):260–264
Younis N, Soran H, Bowen-Jones D (2002) Insulin glargine: a new basal insulin analogue. QJM 95(11):757–761
Acknowledgements
This research was undertaken under the frame of National Centre of Research and Development PBS2/A27/09/2013. The authors gratefully acknowledge the reviewer for putting their attention to published work of Patil et al. (2017), which appeared nearly concurrently to the present submission.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sitkowski, J., Bocian, W., Bednarek, E. et al. Insight into human insulin aggregation revisited using NMR derived translational diffusion parameters. J Biomol NMR 71, 101–114 (2018). https://doi.org/10.1007/s10858-018-0197-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10858-018-0197-y